Posted on July 14, 2012
This entry was posted in Radiology Physics.
This is one awesome article post.Really looking forward to read more.
A round of applause for your blog.Thanks Again. Really Great.
rrem program new jersey
Appreciate you sharing, great blog.Really looking forward to read more. Fantastic.
Thanks-a-mundo for the blog article.
rrem pathway b
Thanks a lot for the blog post.Thanks Again. Really Cool.
A round of applause for your blog post.Really thank you! Want more.
Car Hire Modlin Airport
Thanks for sharing, this is a fantastic blog post.Really thank you! Fantastic.
website templates for dreamweaver
Very good blog post.Much thanks again. Really Cool.
Enjoyed every bit of your post. Cool.
Great blog post. Want more.
opinie o produktach
Im thankful for the article post.Really looking forward to read more. Want more.
slow windows 7
Wow, great article post.Really looking forward to read more. Fantastic.
Leather furniture cleaning DC
Very informative blog.Really thank you! Really Cool.
good chemistry tuition in singapore
Im obliged for the blog post.Much thanks again. Fantastic.
Muchos Gracias for your blog article. Cool.
cheap man and van
A big thank you for your post.Thanks Again. Want more.
best tablet for the money
Keep up the fantastic piece of work, I read couple of posts on this internet internet site and I feel that your blog is actually interesting and holds bands of amazing details.
Anne, we will investigate!
I didn’t realize that athletes could not tie in an engaging screen presence that has really made Shawn Johnson on the resurrected “90210” primetime soap opera, which helped get her to succeed. Not only is she an excellent student but she seems to looking forward to the next Mary Lou Retton and Carly Patterson.
PET with Florbetapir Predicts Cognitive Decline
By Marijke Vroomen Durning, RN | July 11, 2012
A new radioactive agent used with PET imaging of the brain detects early evidence of Alzheimer’s in patients with mild decline or who are not yet showing cognitive impairment, say researchers in a study published today in the journal Neurology.
Researchers from Duke University Medical Center studied 151 patients enrolled in a 36-month multi-center test of the new radioactive agent, florbetapir, brand name Amyvid, which was approved by the FDA in April.
Patients underwent cognitive exams and PET imaging with florbetapir at the start of the study. The agent binds to amyloid plaques that characterize Alzheimer’s disease. The patients were reassessed with additional cognitive exams at 18 months and again at 36 months. Sixty-nine patients had normal cognitive function at the start of the study, 51 had mild impairment and 31 had Alzheimer’s dementia.
The researchers found that patients who had plaques and mild cognitive impairment at the start of the study worsened to a great degree when performing cognitive tests at 18 months compared to patients with no plaques at the start of the study. Twenty-nine percent of patients with plaques developed dementia, compared with 10 percent who had no plaques.
Differences were also seen among patients who had plaques at the start of the study but who showed no signs of cognitive impairment. These patients also demonstrated a mental decline at the 18-month testing mark.
“Even at a short follow-up of 18 months we can see how the presence of amyloid plaques affects cognitive function,” said P. Murali Doraiswamy, MD, professor of radiology at the university and one of the study’s co-leaders. “Most people who come to the doctor with mild impairment really want to know the short-term prognosis and potential long-term effect.”
Addressing the issue of test anxiety or concentration problems, the researchers reported that patients with negative scans reversed from minimally impaired to normal more often than did those with positive PET scans.
The data need to be verified by further research, said Doraiswamy. He also cautioned that a positive scan using florbetapir is not a diagnosis of Alzheimer’s disease.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Notify me of new posts via email.